Dhampur Bio Organics Reports Net Profit of ₹36.79 Crore in Q1 FY27

The Board of Directors of Dhampur Bio Organics Limited (DBOL) today approved the company's unaudited consolidated financial results for the first quarter of the fiscal year 2026-27, ended June 30, 2026. The bio-sugar and chemical producer recorded a sharp turnaround in its total net profitability, jumping into the green on the back of a substantial exceptional windfall from a capital asset divestment, despite ongoing margin pressures in its continuing operations.

Operations Topline Rebounds; Continuing Business Posts Loss

Dhampur Bio Organics reported consolidated revenue from operations of ₹918.56 crore for Q1 FY27. This represents a healthy 22.37% growth year-on-year compared to the ₹750.64 crore recorded in the corresponding quarter last year (Q1 FY26), and a sequential increase of 32.46% over the ₹693.45 crore logged during the March 2026 quarter (Q4 FY26). Including other operating income, total income from continuing operations for the quarter stood at ₹919.77 crore.

However, elevated operational inputs strained profitability. Total expenses from continuing operations climbed to ₹938.06 crore, up from ₹773.01 crore in the parallel year-ago period. A significant driver of this cost increment was a spike in excise duties on the sale of goods, which jumped to ₹385.67 crore against ₹258.16 crore in Q1 FY26.

Consequently, the company reported a pre-tax loss from continuing operations of ₹18.29 crore for the quarter, which represents a slight improvement over the pre-tax loss of ₹20.88 crore recorded in Q1 FY26. After factoring in a deferred tax benefit of ₹4.60 crore, the net loss from continuing operations finished at ₹13.75 crore, compared to a net loss of ₹14.09 crore in the same period last year.

Divestment Gain Drives Overall Net Profit

The bottom-line performance was entirely turned around by the accounting treatment of the company's discontinued business units. Dhampur Bio Organics recorded an operational pre-tax loss of ₹1.71 crore from discontinued units during the three-month period. However, this was heavily offset by a massive gain on the sale of an undertaking amounting to ₹63.89 crore.

This lifted the total pre-tax profit from discontinued operations to ₹62.18 crore. After counting a related tax outgo of ₹11.64 crore, the net profit from discontinued operations settled at ₹50.54 crore, completely turning around a net loss of ₹7.91 crore in Q1 FY26.

Combining both core processing operations and the strategic asset sale, Dhampur Bio Organics delivered a total consolidated Profit for the Period of ₹36.79 crore in Q1 FY27. This highlights a sharp reversal from the ₹22.00 crore net loss posted during the parallel quarter last year. Total comprehensive income for the period finished at ₹36.78 crore.

Per-Share Earnings and Capital Structure

Reflecting the asset monetization structure, the company's Earnings Per Share (EPS) split significantly across operational classifications:

Continuing Operations: Basic and diluted EPS remained negative at -₹2.09 and -₹2.08 respectively on a face value of ₹10 per share.

Discontinued Operations: Basic EPS stood positive at ₹7.68, with diluted EPS at ₹7.64.

Consolidated Entity: The overall basic EPS landed at ₹5.59 per share, shifting into positive territory from the negative EPS of -₹3.31 reported in Q1 FY26.

The company's paid-up equity share capital remained unchanged at ₹66.39 crore, while its overall accumulated other equity stood at ₹960.25 crore at the close of the reporting timeline.

Shares of Dhampur Bio Organics Limited was last trading in BSE at Rs. 117.95 as compared to the previous close of Rs. 117.35. The total number of shares traded during the day was 20323 in over 208 trades.

The stock hit an intraday high of Rs. 122.95 and intraday low of 114.05. The net turnover during the day was Rs. 2443197.00.

Source : Equity Bulls

Keywords

DhampurBioOrganics INE0I3401014 Sugar Q1FY27 Q1FY2027 ResultUpdate